Classical Rett syndrome (RTT) is a rare progressive neurodevelopmental disorder associated with mutations in the MECP2 gene. This study aims to correlate the genetic mutations and phenotype characteristics of a cohort of RTT syndrome patients and evaluate their amenability to novel therapies, including Trofinetide. This evidence concerns the gene MECP2 and neurodevelopmental disorder.